NEWSConcern about the cost of GLP-1s remains high, and a new study suggests it's not uncommon for patients to overpay for these drugs.

NEWS92 percent of prescriptions could have been filled at a lower price, with better information on pricing, dispensing options and manufacturer cost-savings programs.

NEWSAs AI has evolved to be more accurate and reliable, it's become suitable for high-stakes use cases including automating health insurance verification.